These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12792785)

  • 1. DNA variants of DLC-1, a candidate tumor suppressor gene in human hepatocellular carcinoma.
    Park SW; Durkin ME; Thorgeirsson SS; Popescu NC
    Int J Oncol; 2003 Jul; 23(1):133-7. PubMed ID: 12792785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1.
    Ng IO; Liang ZD; Cao L; Lee TK
    Cancer Res; 2000 Dec; 60(23):6581-4. PubMed ID: 11118037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.
    Wong CM; Lee JM; Ching YP; Jin DY; Ng IO
    Cancer Res; 2003 Nov; 63(22):7646-51. PubMed ID: 14633684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells.
    Zhou X; Thorgeirsson SS; Popescu NC
    Oncogene; 2004 Feb; 23(6):1308-13. PubMed ID: 14647417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
    Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
    Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas.
    Yuan BZ; Jefferson AM; Baldwin KT; Thorgeirsson SS; Popescu NC; Reynolds SH
    Oncogene; 2004 Feb; 23(7):1405-11. PubMed ID: 14661059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutation analysis of the tumor suppressor gene PTEN/MMAC1/TEP1 in human hepatocellular carcinoma].
    Zhang LN; Zha XL; Yu Q; He JY
    Shi Yan Sheng Wu Xue Bao; 2000 Sep; 33(3):223-7. PubMed ID: 12549040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930.
    Li Y; Chen Z
    Cancer Lett; 2004 Jun; 209(1):75-85. PubMed ID: 15145523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.
    Yuan BZ; Zhou X; Durkin ME; Zimonjic DB; Gumundsdottir K; Eyfjord JE; Thorgeirsson SS; Popescu NC
    Oncogene; 2003 Jan; 22(3):445-50. PubMed ID: 12545165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma.
    Saffroy R; Riou P; Soler G; Azoulay D; Emile JF; Debuire B; Lemoine A
    Eur J Hum Genet; 2002 Apr; 10(4):239-44. PubMed ID: 12032731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP.
    Yuan BZ; Miller MJ; Keck CL; Zimonjic DB; Thorgeirsson SS; Popescu NC
    Cancer Res; 1998 May; 58(10):2196-9. PubMed ID: 9605766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression.
    Lu X; Feng X; Man X; Yang G; Tang L; Du D; Zhang F; Yuan H; Huang Q; Zhang Z; Liu Y; Strand D; Chen Z
    Clin Cancer Res; 2009 May; 15(10):3287-96. PubMed ID: 19447873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.
    Ko FC; Yeung YS; Wong CM; Chan LK; Poon RT; Ng IO; Yam JW
    Liver Int; 2010 Jan; 30(1):139-48. PubMed ID: 19874489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
    Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
    Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor.
    Pang JC; Chang Q; Chung YF; Teo JG; Poon WS; Zhou LF; Kong X; Ng HK
    Hum Pathol; 2005 Jan; 36(1):36-43. PubMed ID: 15712180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma.
    Di Benedetto M; Pineau P; Nouet S; Berhouet S; Seitz I; Louis S; Dejean A; Couraud PO; Strosberg AD; Stoppa-Lyonnet D; Nahmias C
    Mol Cell Endocrinol; 2006 Jun; 252(1-2):207-15. PubMed ID: 16650523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.